ClinicalTrials.gg
CompletedNCT02322437Updated Jun 6, 2018

Home Treatment for Acute Psychiatric Care

An interventional study of Home treatment and Treatment As Usual in Mental Disorders, sponsored by Psychiatric Services Aargau AG. Completed at 1 site in Switzerland. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2018-06-06.

Sponsored by Psychiatric Services Aargau AG · Not applicable, Interventional, and Health services research

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
707
Allocation
Randomized
Ages
18 Years to 64 Years
Sex
All
01

Study summary

This study aims to evaluate whether psychiatric home treatment is an effective and efficient alternative to acute inpatient care in mental hospitals. A one-year prevalence cohort of psychiatric patients in need of hospitalization are randomly assigned to either treatment at inpatient wards (treatment as usual) or a new care model with the additional option of treating patients at their homes by mobile care teams. The primary focus is on checking whether optional home treatment leads to a reduction of inpatient days during a two-year follow-up period. In addition, the two service models will be compared regarding treatment cost and outcomes as well as satisfaction of patients and their relatives with psychiatric care.

Furthermore, a sub-cohort of randomly chosen patients from the prevalence-cohort will be examined by a highly trained clinical assessor to test and verify the diagnoses and the clinical ratings made by the staff members of the mental hospital under routine everyday conditions.

Read the detailed description

This study aims to evaluate whether psychiatric home treatment is an effective and efficient alternative to acute inpatient care in mental hospitals. A one-year prevalence cohort of psychiatric patients in need of hospitalization are randomly assigned to either treatment at inpatient wards (treatment as usual) or a new care model with the additional option of treating patients at their homes by mobile care teams. The primary focus is on checking whether optional home treatment for crisis intervention leads to a reduction of inpatient days during a two-year follow-up period. In addition, the two service models will be compared regarding treatment cost and outcomes as well as satisfaction of patients and their relatives with psychiatric care.

Furthermore, a sub-cohort of randomly chosen patients from the prevalence-cohort will be examined by a highly trained clinical assessor to test and verify the diagnoses (SCID-I and SCID-II) and the clinical ratings (HoNOS) made by the staff members of the mental hospital under routine everyday conditions.

02

Conditions studied

  • Mental Disorders

Browse trials for

03

In context

Mental Disorders

1,746 studies on the registry are indexed under Mental Disorders; 350 are open to participants now.

This study's enrollment of 707 is above the median of 100 across 1,305 interventional studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

Psychiatric Services Aargau AG is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Need for acute psychiatric inpatient care
  • Residence in the canton of Aargau
  • Living within 30 minutes (by car) from the headquarters of the home treatment team
  • Health insurance with tarifsuisse

Exclusion criteria

Exclusion Criteria:

  • Insufficient proficiency in German
  • Main diagnosis F0 or F1 (ICD-10)
  • Patients of the forencic departement
  • Patients of the child and adolescent department
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
707 participants (actual)

Study arms

  • Experimental
    Home treatment

    Patients in need of acute psychiatric inpatient care are treated at their houses by mobile treatment teams instead of treatment at mental hospitals whenever home treatment is possible and appropriate.

    Other: Home treatment

  • Active comparator
    Treatment as usual

    Patients in need of acute psychiatric inpatient care are treated at a mental hospital.

    Other: Treatment As Usual

Interventions

  • OtherHome treatment

    Patients are treated at home whenever possible and appropriate

  • OtherTreatment As Usual

    Patients are treated at a mental hospital

06

What researchers measure

Primary outcomes

  1. Number of inpatient days

    Time frame: 2 years follow-up

Secondary outcomes

  1. Total days in treatment (inpatient + home treatment)

    Time frame: 2 years follow-up

  2. Direct treatment costs

    Time frame: 2 years follow-up

  3. Health of the Nation Outcome Scales (HoNOS)

    Participants will be followed for the duration of hospital stay, an expected average of 4 weeks.

    Time frame: Intake and discharge from treatment episode (expected average of 4 weeks)

  4. Brief Symptom Checklist (BSCL)

    Participants will be followed for the duration of hospital stay, an expected average of 4 weeks.

    Time frame: Intake and discharge from treatment episode (expected average of 4 weeks)

  5. Perceptions of Care-18

    Participants will be assessed at discharge from hospital, after an expected average of 4 weeks.

    Time frame: Discharge from treatment episode (expected average of 4 weeks)

  6. Satisfaction of patients' relatives

    Relatives' satisfaction will be assessed with an adapted version of the Perceptions of Care-18 questionnaire at discharge of the patients from hospital, after an expected average of 4 weeks. The proportion of satisfied relatives will be reported for both study arms.

    Time frame: Discharge from treatment episode (expected average of 4 weeks)

  7. Number of rehospitalizations per patient

    Time frame: 2 years follow-up

  8. Number of patients with adverse events

    E.g. suicide or attempted suicide.

    Time frame: 2 years follow-up

07

Study locations

1 site
  • Psychiatric Services Aargau AG
    Brugg, Aargau 5201, Switzerland
08

References and documents

Publications

  • Stulz N, Wyder L, Maeck L, Hilpert M, Lerzer H, Zander E, Kawohl W, Grosse Holtforth M, Schnyder U, Hepp U. Home treatment for acute mental healthcare: randomised controlled trial. Br J Psychiatry. 2020 Jun;216(6):323-330. doi: 10.1192/bjp.2019.31. PubMed 30864532 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2015 to primary completion in Apr 2018, 36 months.

Of 668 non-industry interventional studies with no phase under Mental Disorders, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 45. This study's 36 months is above that.

Counting every sponsor, half of 682 studies reached it within 29 months; a quarter within 13 and three quarters within 45.

Mental Disorders covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 11, 2014
First posted
Dec 23, 2014
StartActual
Apr 2015
Primary completionActual
Apr 2018
CompletionActual
Apr 2018
Last update
Jun 6, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 6, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02322437
Lead sponsor
Psychiatric Services Aargau AG
Collaborators
Hugo & Elsa Isler Foundation
Responsible party
Niklaus Stulz (PhD, Psychiatric Services Aargau AG) — Principal investigator
First posted
Dec 23, 2014
Start date
Apr 2015
Primary completion
Apr 2018
Completion
Apr 2018
Last update
Jun 6, 2018

Study contacts

Niklaus Stulz, PhD
principal investigator · Psychiatric Services Aargau AG

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion